AstraZeneca PLCAZN:LSE

38.50 / 0.88%
Close in GBXToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Jul 29 2014 17:00 BST.

Search 783 articles on AstraZeneca PLC

GSK's Witty fights back amid bribery scandal and profit warning
Companies diary: July 28 - August 3
Far from the madding crowd - and better for it
GSK cuts guidance as sales and profits slide
US warned of up to 25 groups eyeing foreign switch to cut tax
AbbVie rounds on US tax laws as it snares Shire
AstraZeneca unveils plans for £330m R&D centre in Cambridge
AbbVie set to unveil £31bn Shire takeover
Jack Lew pushes US Congress to crack down on tax inversions
Eli Lilly joins forces with UK biotech to develop cancer drugs

Reuters News Service company announcements are delayed by up to one hour.

© Thomson Reuters Click for restrictions.

All markets data located on is subject to the FT Terms & Conditions.

All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.